The discovery of a recurring 'AGGTG' microhomology sequence at the duplication breakpoints suggests that specific DNA repair mechanisms are responsible for these complex PIGN gene disruptions. This finding represents a significant leap in our understanding of Multiple Congenital
Transitioning to a software-defined laboratory model allows researchers to change scientific protocols without making major mechanical overhauls. The global pharmaceutical industry is currently witnessing an unprecedented pivot from mass-market pharmaceutical blockbusters to highly targeted genetic
Advancing Immunotherapy in the Global Oncology Landscape The current trajectory of global oncology research is defined by a rigorous departure from generalist treatments toward sophisticated, molecularly targeted therapies that prioritize long-term patient survival over temporary remission. In
While approximately 95.7 percent of Nigerian breast cancer patients express readiness for genetic testing, the vast majority have a mean correct response rate of only 20.5 percent regarding recognized risk factors. The epidemiological landscape of Nigeria has undergone a profound transformation as
The pharmaceutical industry has long grappled with the 'Eroom’s Law' phenomenon, where the cost of developing a new drug doubles approximately every nine years despite major technological advances, making the quest for efficiency a matter of global health survival. This struggle has reached a
Legislative progress in 25 states has mandated biomarker testing coverage, yet many patients still face prohibitive cost-sharing requirements and frequent insurance denials for innovative modalities. The promise of precision medicine—the tailoring of medical treatment to the individual
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158